Healthcare -
Biotechnology - NASDAQ - US
$ 1.4223
-2.67 %
$ 21.3 M
Market Cap
-0.56
P/E
LGVN - TOTAL EQUITY
Total Equity LGVN - Longeveron Inc.
21.9 M
LAST VALUE
3.32%
2 YEAR CAGR
37.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR